Michael J. Pellini's most recent trade in Adaptive Biotechnologies Corp was a trade of 23,726 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 04 Mar 2025 | 23,726 | 23,726 | - | - | Stock Option (right to buy) | ||
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 04 Mar 2025 | 15,394 | 69,690 (0%) | 0% | 0 | Common Stock | ||
| Singular Genomics Systems Inc | Michael J. Pellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | ||
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 04 Mar 2024 | 31,328 | 54,296 (0%) | 0% | 0 | Common Stock | ||
| Singular Genomics Systems Inc | Michael J. Pellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 06 Mar 2023 | 23,329 | 23,329 | - | - | Stock Option (right to buy) | ||
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 06 Mar 2023 | 14,775 | 22,968 (0%) | 0% | 0 | Common Stock | ||
| Singular Genomics Systems Inc | Michael J. Pellini | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 72,455 | 26,834 | - | 0 | Common Stock | |
| GeneDx Holdings Corp - Ord... | Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 4,278 | 17,114 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 4,278 | 8,558 | - | - | Restricted Stock Unit | |
| Singular Genomics Systems Inc | Michael J. Pellini | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 May 2022 | 154,939 | 99,289 | - | 0 | Common Stock | |
| Singular Genomics Systems Inc | Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.21 per share. | 31 May 2022 | 60,668 | 159,957 | - | 0.2 | 12,789 | Common Stock |
| Singular Genomics Systems Inc | Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 60,668 | 0 | - | - | Stock Option (Right to Buy) | |
| Singular Genomics Systems Inc | Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. | 31 May 2022 | 60,000 | 254,228 | - | 0.6 | 37,800 | Common Stock |
| Singular Genomics Systems Inc | Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Singular Genomics Systems Inc | Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 31 May 2022 | 34,271 | 194,228 | - | 0.2 | 8,054 | Common Stock |
| Singular Genomics Systems Inc | Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 34,271 | 0 | - | - | Stock Option (Right to Buy) | |
| Singular Genomics Systems Inc | Michael J. Pellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 62,500 | 62,500 | - | - | Stock Option (Right to Buy) | |
| Singular Genomics Systems Inc | Michael J. Pellini | Director | Purchase of securities on an exchange or from another person at price $ 3.30 per share. | 18 May 2022 | 26,834 | 99,289 | - | 3.3 | 88,552 | Common Stock |
| GeneDx Holdings Corp - Ord... | Michael J. Pellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 78,914 | 78,914 | - | - | Stock Option | |
| GeneDx Holdings Corp - Ord... | Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 12,836 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Michael J. Pellini | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Michael J. Pellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 22,286 | 22,286 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Michael J. Pellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 22,286 | 22,286 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Michael J. Pellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 12,836 | 12,836 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Michael J. Pellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 12,836 | 12,836 | - | - | Restricted Stock Unit | |
| Singular Genomics Systems Inc | Michael J. Pellini | Director | 01 Jun 2021 | 96,944 | 96,944 | - | - | Common Stock | ||
| Singular Genomics Systems Inc | Michael J. Pellini | Director | 01 Jun 2021 | 96,944 | 0 | - | - | Series A Preferred Stock | ||
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 01 Mar 2021 | 20,000 | 55,000 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 01 Mar 2021 | 20,000 | 1,504 (0%) | 0% | 57.8 | 1,156,000 | Common Stock | |
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 01 Mar 2021 | 20,000 | 21,504 (0%) | 0% | 6.6 | 131,000 | Common Stock | |
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 14 Feb 2021 | 3,759 | 3,759 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 14 Feb 2021 | 1,504 | 1,504 (0%) | 0% | 0 | Common Stock | ||
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 21 Dec 2020 | 25,000 | 0 (0%) | 0% | 60 | 1,500,000 | Common Stock | |
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 21 Dec 2020 | 25,000 | 75,000 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 21 Dec 2020 | 25,000 | 25,000 (0%) | 0% | 6.6 | 163,750 | Common Stock | |
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 14 Oct 2020 | 50,000 | 50,000 (0%) | 0% | 6.6 | 327,500 | Common Stock | |
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 14 Oct 2020 | 50,000 | 100,000 | - | - | Stock Option (Right to Buy) | ||
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 14 Oct 2020 | 28,255 | 21,745 (0%) | 0% | 51.9 | 1,466,152 | Common Stock | |
| Adaptive Biotechnologies Corp | Michael J. Pellini | Director | 14 Oct 2020 | 21,745 | 0 (0%) | 0% | 53.0 | 1,151,398 | Common Stock |